Private Companies 26

USA

April 17, 2018: Genelux Corp issued new U.S. patent [9,944,903]

NEWS BITES - PRIVATE COMPANIES

Genelux Corp has been issued a new U.S. patent titled "Modified vaccinia virus strains for use in diagnostic and therapeutic methods" by the US Patent and Trademark Office.

ABSTRACT

Modified viruses and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including cancer, and as anti-tumor and/or antiangiogenic agents. The viruses also can be used in diagnostic methods.

Appl. No.14/638,604

INDEX

SECTION 1 GENELUX CORP PROFILE

SECTION 1 GENELUX CORP PROFILE

1.1 SUMMARY

Website: http://www.genelux.com/

Created by www.buysellsignals.com for News Bites Finance